pharma · Urea cycle disorders (UCD) · Cannabis Smoking · CAMP
Camp4 Therapeutics
Camp4 Therapeutics Corp
Camp4 Therapeutics is a pharma organization headquartered in Cambridge, USA. It trades on NYSE under ticker CAMP. Primary therapeutic focus areas include Urea cycle disorders (UCD), Cannabis Smoking, Subjective Tinnitus,
Cambridge, USA HQ
2016 Founded
60 Employees
Public company Type
CAMP · NYSE Ticker
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Founded
- 2016
- Employees
- 60
- Programs
- 9
- Drugs
- 15
- Patents
- 4
Ketamine Hydrochloride
Phase 3 · small molecule · Suicide
Ketamine Hydrochloride for Suicide is a Phase 3 program (small_molecule) at Camp4 Therapeutics Corp with 1 ClinicalTrials.gov record(s).
Internal code NMCCL.2018.0011
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Camp4 Therapeutics Corp
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Suicide
- Status
- terminated
- Trials
- 1